Langhao Medical Technology (Hunan) Co., Ltd. announced that it has signed an agreement and issued common shares for a total gross proceeds of CNY 4 million in September, 2022. The transaction included participation from new investor, Tibet Duo Rui Pharmaceutical Co.,Ltd. for 25% stake. Out of CNY 4 million, CNY 3.3333 million is in registered capital and the rest in capital reserve.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 CNY | -0.44% |
|
-1.30% | -40.38% |
1st Jan change | Capi. | |
---|---|---|
-40.38% | 17Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Langhao Medical Technology Co., Ltd. announced that it has received CNY 4 million in funding from Tibet Duo Rui Pharmaceutical Co.,Ltd.